Pharmaceutical Commerce

Featured Content

Pharmaceutical Commerce - August 2025

Click here to read the articles and view the interactive digital edition

Pharma Wholesalers: Looking for Growth

Despite the ongoing turmoil over tariffs, medicine costs, and FDA policy, US wholesalers are performing well.

Popping the Gross-to-Net Bubble, Part V: Innovative Pricing Models

From rethinking launch price logic to implementing rebate-aware modeling and patient-first access programs, this installment explores how disciplined governance and forward-thinking models can safeguard profitability in a volatile market.

340B Litigation and the Path Toward Transparent Drug Discount Programs

As pharma drug pricing debates heat up, the 340B program faces mounting challenges from outdated regulations, duplicate discounts, and limited transparency.

Pharma Pulse 6/18/25: The Complexities of Drug Discounting; How Clinical Operations Teams Are Adapting to Oncology Trial Challenges

June 18, 2025

Bolstering Health Technology Assessment With the Help of AI

June 17, 2025

Ways to address limitations while also enhancing the decision-making process.

Changing the PAP Model

June 17, 2025

The advantages and challenges associated with structuring a patient assistance program as a non-profit foundation.

United States, United Kingdom Reach Tariff-Lowering Deal

June 17, 2025

Though this specific agreement centers around aerospace and automobiles, the greater supply chain will wait and see how Trump’s import taxes impact pharmaceuticals, a sector that faces a potential 25% tax on imports.

Building Intelligent Pharma Supply Chain Management with Real-World Data

June 17, 2025

Approaches powered by RWD can clear the way for a greater focus on patient-centered care.

Analysis of the MFN Executive Order

June 17, 2025

In the first part of her Pharma Commerce video interview, LeAnn Boyd, Liviniti’s founder and CEO, outlines the most critical root causes of rising healthcare and drug costs that the MFN executive order doesn’t address.

Pharma Pulse 6/17/25: How AI and Regulation are Reshaping the Future of Drug Safety; A Reflection on Our Path Forward

June 17, 2025

Policy Whiplash? 24 Hours in the Hub Still Matters More

June 16, 2025

Doubling down on patient access and support fundamentals will win out over Washington’s next move.

Raising the Alarm

June 16, 2025

Healthcare providers must enhance awareness of counterfeit medicines to protect patients, especially as online drug purchases rise.

UCB to Invest $5 Billion into US Production Plant

June 16, 2025

The biopharma company—whose US headquarters is in Atlanta—will be building a new biologics manufacturing facility in a city to be named at a later date.